Biolegend, 306002, Purified anti-human CD123 Antibody, 100μg

CD123 is the 70 kD transmembrane α chain of the IL-3 receptor. Alone, CD123 binds IL-3 with low affinity; when CD123 associates with CD131 (common β chain), it binds IL-3 with high affinity. CD123 does not transduce intracellular signals upon binding IL-3 and requires the β chain for this function. CD123 is expressed by myeloid precursors, macrophages, dendritic cells, mast cells, basophils, megakaryocytes, and some B cells.
100μg
Verified Reactivity: Human
Reported Reactivity: Rhesus
Antibody Type: Monoclonal
Host Species: Mouse
Immunogen: Human IL-3Rα transfected COS cells.
Formulation: Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation: The antibody was purified by affinity chromatography.
Concentration: 0.5 mg/ml
Storage & Handling: The antibody solution should be stored undiluted between 2°C and 8°C.
Application: FC - Quality tested CyTOF® - Verified IHC-F, IP, WB - Reported in the literature, not verified in house
Recommended Usage: Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 1.0 µg per million cells in 100 µl volume or 100 µl of whole blood. It is recommended that the reagent be titrated for optimal performance for each application.
Application Notes: Clone 6H6 does not inhibit IL-3 binding to low- or high-affinity IL-3Rs. Additional reported applications (for the relevant formats) include: Western blotting1, immunoprecipitation1, and immunohistochemical staining of acetone-fixed frozen sections2 and also paraformaldehyde fixed paraffin embedded tissue7.
Application References(PubMed link indicates BioLegend citation): Sun Q, et al. 1996. Blood 87:83. (IP, WB) Herling M, et al. 2003. Blood 101:5007. (IHC) Charles N, et al. 2010. Nat. Med. 16:701. (FC) PubMed Martin-Gayo E, et al. 2010. Blood 115:5366. PubMed Chen SC, et al. 2010. Arch Dermatol Res. 302:113. PubMed Liu Y, et al. 2012. Food Chem Toxicol. 50:1920. PubMed Peduzzi E, et al. 2007. J. Invest. Dermatol. 127:638. (IHC)
Product Citations: Dallari S, et al. 2017. Nat Commun. 8:14830. PubMed Leader AM, et al. 2021. Cancer Cell. 39:1594. PubMed McCarthy EE, et al. 2022. Cell Rep. 39:110815. PubMed Laggner M, et al. 2022. EBioMedicine. 81:104093. PubMed Poon MML, et al. 2023. Nat Immunol. 24:309. PubMed Friebel E, et al. 2020. Cell. 181(7):1626-1642.e20. PubMed Rosa TLSA, et al. 2022. Front Med (Lausanne). 9:899998. PubMed Wagner J et al. 2019. Cell. 177(5):1330-1345 . PubMed Parackova Z, et al. 2020. Sci Rep. 0.759027778. PubMed Kremenovic M, et al. 2020. Cancers (Basel). 12:. PubMed Mann ER, et al. 2020. Sci Immunol. :5. PubMed Kaufmann M, et al. 2021. Med. 2(3):296-312.e8. PubMed Vivanco Gonzalez N, et al. 2022. STAR Protoc. 3:101280. PubMed Li Y, et al. 2019. Front Immunol. 0.460416667. PubMed Martin JC, et al. 2020. Cell. 178(6):1493-1508.e20.. PubMed Syrimi E, et al. 2021. iScience. 24:103215. PubMed O'Boyle KC, et al. 2020. Methods Mol Biol. 2111:1. PubMed Chen S, et al. 2010. Arch Dermatol Res. 302:113. PubMed Olin A, et al. 2018. Cell. 174:1277. PubMed Tripathi T, et al. 2019. Immunohorizons. 0.201388889. PubMed Baskar R, et al. 2022. Cell Rep Methods. 2:. PubMed Liu Y, et al. 2012. Food Chem Toxicol. 50:1920. PubMed Eccles JD, et al. 2020. Cell Rep. 30:351. PubMed Thrash EM, et al. 2020. STAR Protoc. 1:100055. PubMed Martin-Gayo E, et al. 2010. Blood. 115:5366. PubMed Henrick BM, et al. 2021. Cell. . PubMed Roussel M, et al. 2021. Cell Reports Medicine. 2(6):100291. PubMed Kato M, et al. 2021. PLoS One. 16:e0252116. PubMed Liu SQ, et al. 2021. Cancer Immunol Res. 9:34. PubMed Evrard M et al. 2018. Immunity. 48(2):364-379 . PubMed NULL, et al. 2022. Cell. 185:916. PubMed Saygin C, et al. 2021. Leukemia. 35:3406. PubMed Chevrier S, et al. 2021. Cell Reports Medicine. 2(1):100166. PubMed Chevrier S, et al. 2018. Cell Syst. 0.675. PubMed Lavin Y et al. 2017. Cell. 169(4):750-765 . PubMed
RRID: AB_314576 (BioLegend Cat. No. 306002)
Structure: Ig superfamily, type I transmembrane glycoprotein, associates with CDw131, 70 kD
Distribution: Myeloid precursors, basophils, mast cells, macrophages, dendritic cells, megakaryocytes, subset of lymphocytes
Function: Hematopoietic cell proliferation, differentiation
Ligand/Receptor: IL-3
Cell Type: Basophils, Dendritic cells, Hematopoietic stem and progenitors, Lymphocytes, Macrophages, Mast cells, Megakaryocytes
Biology Area: Immunology
Molecular Family: CD Molecules, Cytokine/Chemokine Receptors
Antigen References: 1. Miyajima A, et al. 1993. Blood 82:1960.
Gene ID: 3563
UniProt: View information about CD123 on UniProt.org
Clone: 6H6
Regulatory Status: RUO
Other Names: IL-3Rα, IL-3 Receptor alpha
Isotype: Mouse IgG1, κ